×

Please enter your work email ↴

I am an EU resident
I agree to the storing and processing of my personal data by TrialScope as described in the Privacy Policy.
Yes, sign up for TrialScope emails
Not required for access to this content. Unsubscribe at any time. Privacy Policy
Thank you!
Error - something went wrong!

Why Disclosure Assessments are the First Step to Improvement

Whether your organization lacks formal clinical trial data disclosure policies and procedures or has longstanding SOPs in place, just how efficient is your disclosure process?


That’s the question that UCB answered with a third-party compliance assessment, reviewing clinical trial disclosure requirements specific to the FDAAA Final Rule, and an assessment of study records and related SOPs. Join us for an informational webinar as Liz Roberts of UCB shares insights on her organization’s decision to commission a compliance assessment focused on the FDAAA/Final Rule requirements and the outcome of that assessment.

Previous Flipbook
8 Reasons to Join TrialScope Community
8 Reasons to Join TrialScope Community

Next Article
Why Clinical Trial Sponsors Should Become More Transparent
Why Clinical Trial Sponsors Should Become More Transparent

Due to pressure from patients, healthcare advocates, advocacy groups and the government, the healthcare ind...